Jeroen KOOL (Amsterdam Institute for Molecules Medicines and Systems, The
Netherlands)
Analytics for
assessing venom coagulopathy and neurotoxicity
Michel PARTISETI (Sanofi R&D, Integrated Drug Discovery – High Content Biology,
Vitry-sur-Seine, France)
Venoms in Drug
Discovery: A case study on voltage-gated channels
Nicolas GILLES (SIMOPRO, CEA de Saclay, Gif-sur-Yvette, France)
How to turn the
complexity of venoms into an HTS-compatible toxin bank
Kim ROELANTS (Amphibian Evolution Lab, Vrije Universiteit Brussel, Elsene, Belgium)
Poison from a
frog's perspective: Tracing the evolution and adaptive roles of anuran
antimicrobial peptides
Pal STENMARK (Department of Biochemistry and Biophysics, Stockholm University,
Stockholm, Sweden)
The Clostridial
neurotoxins, a growing family
Gabriella VIERO (Institute of Biophysics, CNR Unit, Trento, Italy)
A host lncRNAs
protects human cells from bacterial infection and aids against infection by
associating with polysomes
Christian GRUBER (Center for Physiology and Pharmacology, Medical University of Vienna,
Austria)
Plant cystine-knot
peptide toxins as pharmacological research tools and therapeutic drug
candidates
Antonio VILLAVERDE (Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de
Barcelona, Spain)
Engineering protein
toxins as self-assembling, self-delivered antitumoral drugs